QSOX1 Inhibitors Development into a Clinically Applicable Anticancer Drug by Generating RCC Mouse Xenograft Models QSOX1 inhibitors development into a clinically applicable anticancer drug by generating RCC mouse xenograft models
|Effective start/end date||8/2/15 → 9/15/16|
- Mayo Clinic Arizona: $41,127.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.